co.don AG Book/Share
What is the Book/Share of co.don AG?
The Book/Share of co.don AG is 0.57
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on XETRA compared to co.don AG
What does co.don AG do?
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Companies with book/share similar to co.don AG
- Diaceutics Plc has Book/Share of 0.57
- Altaley Mining has Book/Share of 0.57
- Lorne Park Capital Partners has Book/Share of 0.57
- Selecta Biosciences Inc has Book/Share of 0.57
- Nextedia SA has Book/Share of 0.57
- Jubilee Gold Exploration has Book/Share of 0.57
- co.don AG has Book/Share of 0.57
- Falco Resources has Book/Share of 0.57
- Tianli has Book/Share of 0.57
- ECI Technology has Book/Share of 0.57
- Dragon Victory International Ltd has Book/Share of 0.57
- e Athena has Book/Share of 0.57
- Yida China has Book/Share of 0.57